INTRA-ARTICULAR THERAPY IN ARTHRITIS
Injection of substances as diverse as iodized oil and lactic acid have been used in the past to suppress arthritic inflammation. Hydrocortisone was first given by intra-articular injection by Thorn (I95i), but it was not until Hollander et al. (I95I) reported considerable and consistent improvement from injections of hydrocortisone acetate into the affected synovial spaces of arthritic patients that this form of treatment was generally adopted. The encouraging early results were confirmed by Stevenson et al. (1952) , Duff et al. (1952) and De Seze et al. (I952) .. Cortisone, on the other hand, proved to have an inconsistent local anti-rheumatic effect when injected into joints, leading in some cases to local irritation rather than relief. The difference is thought to result from more rapid tissue utilization of hydrocortisone, whilst cortisone has first to be metabolized under as yet undefined conditions. Technique of Injection Ordinary aseptic precautions are taken with or without local anaesthesia, depending on the ease of entry into the joint cavity. Detailed descriptions of procedure for injection of the various joints have been described elsewhere (Hollander, 1953 The mechanism by which hydrocortisone ameliorates arthritic inflammation is obscure. The local effect is more than simple analgesia, because studies of the synovial fluid from rheumatoid joints after the intra-articular injection of hydrocortisone show a fall in the number of neutrophil cells, a decrease in joint temperature and a significant increase in viscosity (Yielding et al., 1956 ). Harris et al. (1958) , using radioactive sodium clearance from a joint as a quantitative measure of the local circulation, showed that this correlated well with the local activity of the disease. After injection of 50 mg. of hydrocortisone acetate a reduction in clearance rate towards normal was observed.
Injected microcrystals of hydrocortisone quickly disappear from the synovial fluid, being absorbed and retained by the synovial lining cells (Hollander et al., 1955 None of these studies were made in strictly controlled conditions. In a double-blind crossover trial, Chandler et al. (1958) (I957) reported that the trimethyl acetate derivative of prednisolone possessed a therapeutic efficiency superior to all other compounds previously used. Personal experience with these newer compounds suggests that their advantages over hydrocortisone are slight.
Dangers of Intra-Articular Therapy Hollander (I953) was impressed by the infrequency and almost universally mild character of adverse effects from intra-articular hydrocortisone injections. Of the 8,693 injections given, only I99 (2.3 per cent.) were followed by some untoward reaction, usually a temporary exacerbation of the arthritis. A few patients complained of weakness, either local or general, after injection and four patients developed urticaria at the site of injection. The most serious immediate local com- plication, septic arthritis, is fortunately rare, but its occasional occurrence demands scrupulous attention to aseptic practice on the part of the operator. Deep-vein thrombosis is sometimes seen in the injected leg but it is difficult to know if this is a true complication of treatment.
A potentially more serious criticism of this form of treatment has been the report of radiological deterioration, sometimes considerable, in the knees of io of i8 patients with rheumatoid arthritis who took part in a controlled trial of intra-articular steroid therapy (Chandler and Wright, I958) . The three most useful measurements of joint function (pain, walking time, and range of movement) were considered separately in relation to radiological change. No significant association could be traced between the effects of treatment on pain and range of movement in the two groups of patients with and without radiological progression of arthritis. Improvement in walking time, however, was significantly greater in the group with deterioration. It was concluded that the principal effect of treatment in this group had been the attainment of a standard of performance beyond the capacity of the joint, the very success of treatment carrying with it the threat of accelerating joint destruction. An example of deterioration after intra-articular injections of hydrocortisone is shown in Fig. i . The same authors (Chandler et al., 1959) have reported the production of a virtual Charcot's arthropathy in an osteo-arthritic hip treated over an i8-month period by monthly injections of hydrocortisone. It was considered that the chief cause for radiological progression in these cases was the encouragement of a degree of weight-bearing and mobility which was inherently traumatic.
The implication of these studies is clearly that intra-articular treatment with hydrocortisone should not be allowed more than an adjuvant place in the rehabilitation of the chronic rheumatic patient. Limitation of weight-bearing activities, muscle retraining, and other local and general measures of treatment emphatically remain of first importance. Intra-articular therapy demands particular restraint on the part of the physician, for the symptomatic benefit experienced by the patient may encourage a vicious circle of dependence despite worsening disease. Strict radiological supervision is advisable if prolonged intraarticular administration of hydrocortisone and related compounds is undertaken.
Summary and Conclusions
Undoubtedly intra-articular therapy with hydrocortisone provides a useful additional measure for the treatment of arthritis and generally gives clinical improvement which is encouraging to the physician and appreciated by the patient. It is particularly valuable as an adjunct to the treatment of rheumatoid arthritis in patients with involvement of only a few joints, or in whom general measures of treatment are adequate except in a few joints. In both rheumatoid arthritis and osteoarthritis it is helpful in the management of patients suffering from acute or subacute exacerbations of disease in whom the maximal application of other conservative measures have failed to relieve discomfort. Intra-articular treatment is impracticable in patients with active involvement of multiple joints and also in arthritis of the spinal joints and, to a lesser extent, the hips which respond poorly because of difficulty of access. Best results are obtained in joints which show signs of active inflammatory change. In patients with advanced joint destruction and where deformity and ankylosis have occurred the treatment is of little value.
The most favourable response to intra-articular treatment occurs in self-limited conditions such as traumatic bursitis and in such localized lesions as tenosynovitis and tendinitis. In periarthritis of the shoulder, intra-articular hydrocortisone may be usefully combined with both physiotherapy and manipulation, and such combined treatment appears to hasten recovery.
It cannot be over emphasized that intra-articular injection of hydrocortisone is a purely palliative procedure, and is not a substitute for systemic therapy; nor should its use be allowed to supplant the need for local supportive measures of treatment. Indeed, the deterioration that has been observed in weight-bearing joints treated by frequent injections of hydrocortisone indicates that more rather than less vigilance is required. As in other diseases, so in arthritis, symptomatic measures must never be allowed to obscure the importance of a total therapeutic approach.
